Sarcopenic obesity evaluated by dual energy X-ray absorptiometry, rather than sarcopenia or obesity alone, is associated with the macrovascular but not microvascular complications in patients with type 2 diabetes

Author:

Li Han1,Su Weijuan2,Li Jia2,Wang Shunhua2,Chen Zheng2,zhang Yuxian2,Huang Bingkun2,Lyu Fuping2,Yan Fangfang2,Huang Caoxin2,Lin Mingzhu2,Shi Xiulin2,Li Xuejun2

Affiliation:

1. Xiamen University

2. the First Affiliated Hospital of Xiamen University, Xiamen University

Abstract

Abstract Objective: The prevalence of Sarcopenic obesity (SO) is increasing, particularly with a rising trend observed in patients diagnosed with Type 2 diabetes (T2D). However, the association between SO and diabetic complications remains unclear when compared to sarcopenia or obesity alone. This study aimed to investigate the associations between sarcopenia, obesity, SO, and diabetes complications in patients with T2D. Methods: A retrospective study was conducted including 2387 hospitalized patients with T2D. Data associated with demographic characteristics, biochemical parameters, diabetic complications, and body composition from electronic health records were collected. The participants were categorized as normal (nonsarcopenia nonobesity), sarcopenia, obesity, and SO groups according to the body compositions evaluated by dual-energy X-ray absorptiometry. Multiple logistic regression models were applied to assess the associations between body composition and complications of diabetes. Results: After adjustment for potential confounders, compared with patients in normal group, the odds ratios (95% CIs) of macrovascular complications of diabetes were 0.64 (95% CI, 0.29-1.42) for those in sarcopenia group, 1.05 (95% CI, 0.56-1.97) in obesity group, and 2.45 (95% CI, 1.18-5.09) in SO group, respectively; the odds ratios (95% CIs) of microvascular complications of diabetes was 0.95 (95% CI, 0.58-1.55) for those in sarcopenia group, 0.80 (95% CI, 0.53-1.22) in obesity group, and 1.21 (95% CI, 0.69-2.11) in SO group, respectively. Conclusion: According to our findings, SO, rather than sarcopenia or obesity alone, was significantly associated with a higher prevalence of macrovascular complications, in hospitalized patients with T2DM. This association was not observed for diabetic microvascular complications.

Publisher

Research Square Platform LLC

Reference24 articles.

1. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms;Massimino E;Cells,2021

2. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme;Messier V,2009

3. Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women;Santos EP;Arch Gerontol Geriatr,2014

4. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives;Koliaki C;Curr Obes Rep,2019

5. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists;Garvey WT,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3